Vitas Pharma
(VITAS PHARMA RESEARCH PRIVATE LIMITED)
Founded in 2010 (Ceased since 2020)
About Vitas Pharma
Vitas Pharma is a startup that specializes in the discovery and development of advanced antimicrobial therapies to combat multidrug-resistant infections. They possess a range of novel compounds with both narrow- and broad-spectrum activity.
Key Founders and Directors of Vitas Pharma
Incubators & Accelerators of Vitas Pharma
+3 more incubators
Public Links of Vitas Pharma
Frequently Asked Questions (FAQ)
When was Vitas Pharma founded?
Vitas Pharma was founded in the year 2010.
What is the legal name of Vitas Pharma?
The legal name of Vitas Pharma is Vitas Pharma Research Private Limited.
Who are the founders of Vitas Pharma?
Vitas Pharma is founded by Radha Rangarajan
Who all are Angel Investors of Vitas Pharma?
Which VC Investors & Angel Networks funded Vitas Pharma?
Which Incubators & Accelerators supported Vitas Pharma?
What are the focus areas of Vitas Pharma?
Who are Vitas Pharma's competitors?
Possible competitors of Vitas Pharma may include Biomoneta, Exocan Healthcare Technologies, Fibroheal and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
